The term “stem cell” by itself can be misleading. In fact, there are many different types of stem cells, each with very different potential to treat disease.
By definition, all stem cells:
- have the ability to divide and create an identical copy of themselves, a process called self-renewal; and
- can also divide to form cells that mature into cells that make up every type of tissue and organ in the body.
Pluripotent means many "potentials". In other words, these cells have the potential of taking on many fates in the body, including all of the more than 200 different cell types. Embryonic stem cells are pluripotent, as are induced pluripotent stem (iPS) cells that are reprogrammed from adult tissues. When scientists talk about pluripotent stem cells they mostly mean either embryonic or iPS cells
Embryonic stem cells come from pluripotent cells, which exist only at the earliest stages of embryonic development. In humans, these cells no longer exist after about five days of development.
When isolated from the embryo and grown in a lab dish, pluripotent cells can continue dividing indefinitely. These cells are known as embryonic stem cells.
James Thomson, a professor of Anatomy at the University of Wisconsin, isolated the first human embryonic stem cells in 1998. He now shares a joint appointment at the University of California, Santa Barbara, a CIRM-funded institution.
What people commonly call adult stem cells are more accurately called tissue-specific stem cells. These are specialized cells found in tissues of adults, children and fetuses. They are thought to exist in most of the body’s tissues and organs.
Adult stem cells are committed to becoming a cell from their tissue of origin, but they still have the broad ability to become a subset of adult cell types. For example:
- Adult stem cells in the bone marrow can give rise to any of the red or white cells of the blood system.
- Adult stem cells in the brain can form all the neurons and support cells of the brain, but can’t form non-brain tissues.
Unlike embryonic stem cells, researchers have not been able to grow adult stem cells indefinitely in the lab.
In recent years, scientists have found stem cells in the placenta and in the umbilical cord of newborn infants. Although these cells come from a newborn they more closely resemble adult stem cells. The cord blood cells that some people bank after the birth of a child are a form of adult blood-forming stem cells.
CIRM-grantee Irving Weissman of the Stanford University School of Medicine isolated the first blood-forming adult stem cell from bone marrow in 1988 in mice and later in humans.
An induced pluripotent stem cell, or iPS cell, is a cell taken from any tissue (usually skin or blood) from a child or adult and is genetically modified to behave like an embryonic stem cell. As the name implies, these cells are pluripotent, which means that they have the ability to form all adult cell types.
Shinya Yamanaka, an investigator with joint appointments at Kyoto University in Japan and the Gladstone Institutes in San Francisco created the first iPS cell from a mouse in 2006. In 2007 several groups of researchers including Yamanaka and James Thomson from the University of Wisconsin and University of California, Santa Barbara generated iPS cells from human skin cells.
Cancer stem cells are a subpopulation of cancer cells that, like stem cells can self-renew. However, these cells—rather than growing into tissues and organs—propagate the cancer, maturing into the many types of cells that are found in a tumor.
Cancer stem cells are a relatively new concept, but they have generated a lot of interest among cancer researchers because they could lead to more effective cancer therapies.
However, there is still debate on which types of cancer are propelled by cancer stem cells. For those that do, cancer stem cells are thought to be the source of all cells that make up the cancer.
Conventional cancer treatments, such as chemotherapy, may only destroy cells that form the bulk of the tumor, leaving the cancer stem cells intact. Once treatment is complete, cancer stem cells that still reside within the patient can give rise to a recurring tumor. Based on this hypothesis, researchers are trying to find therapies that destroy the cancer stem cells in the hopes that it truly eradicates a patient’s cancer.
John Dick from the University of Toronto first identified cancer stem cells in 1997. Michael Clarke, then at the University of Michigan, later found the first cancer stem cell in a solid tumor, in this case breast cancer. Now at Stanford University School of Medicine, Clarke and his group have now found cancer stem cells in colon cancer and head and neck cancers.
Find out More:
UCLA Publication: Stem cells and the origin of cancer
Stanford Publication: The true seeds of cancer